Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States

American Journal of Gastroenterology

Volumn 97, Issue 12, 2002, Pages 3007-3014

  Ladabaum, Uri ^a,b   Fendrick, A Mark ^a,b   Glidden, David ^a,b   Scheiman, James M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; ENDOSCOPY; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PEPTIC ULCER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UPPER GASTROINTESTINAL TRACT;

ADULT; DIAGNOSTIC TESTS, ROUTINE; EDUCATION, MEDICAL, CONTINUING; FEMALE; HEALTH CARE COSTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENTS; PEPTIC ULCER; PHYSICIANS' OFFICES; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 0036896435     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)05535-1     Document Type: Article

References (40)

1. Talley NJ, Silverstein MD, Agreus L, et al. AGA technical review: Evaluation of dyspepsia. Gastroenterology 1998;114: 582-95.
2. Axon AT, Bell GD, Jones RH, et al. Guidelines on appropriate indications for upper gastrointestinal endoscopy. Working Party of the Joint Committee of the Royal College of Physicians of London, Royal College of Surgeons of England, Royal College of Anaesthetists, Association of Surgeons, the British Society of Gastroenterology, and the Thoracic Society of Great Britain. Br Med J 1995;310:853-6.
3. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut 1997;41:8-13.
4. American Gastroenterological Association medical position statement: Evaluation of dyspepsia. Gastroenterology 1998; 114:579-81.
5. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998;13:1-12.
6. Veldhuyzen van Zanten SJ, Flook N, Chiba N, et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. Can Med Assoc J 2000; 162(suppl 12): S3-23.
7. Peterson WL, Fendrick AM, Cave DR, et al. Helicobacter pylori-related disease: Guidelines for testing and treatment. Arch Intern Med 2000;160:1285-91.
8. Sobala GM, Crabtree JE, Pentith JA, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991;338:94-6.
9. Patel P, Khulusi S, Mendall MA, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995;346:1315-8.
10. Fendrick AM, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995;123:260-8.
11. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis. Gastroenterology 1996;110:72-83.
12. Lassen AT, Pedersen FM, Bytzer P, et al. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: A randomised trial. Lancet 2000;356: 455-60.
13. Jones R, Tait C, Sladen G, et al. A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice. Int J Clin Pract 1999;53:413-6.
14. Weingarten S. Translating practice guidelines into patient care: Guidelines at the bedside. Chest 2000;118:4-7S.
15. Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. Br Med J 1998;317:465-8.
16. Ladabaum U, Fendrick AM, Scheiman JM. Outcomes of initial noninvasive Helicobacter pylori testing in U.S. primary care patients with uninvestigated dyspepsia. Am J Gastroenterol 2001;96:2051-7.
17. Chey WD, Murthy U, Shaw S, et al. A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: A United States, multicenter trial. Am J Gastroenterol 1999;94:1512-6.
18. Ladas SD, Malamou H, Giota G, et al. Prospective evaluation of a whole-blood antibody test (FlexPack HP) for in-office diagnosis of Helicobacter pylori infection in untreated patients. Eur J Gastroenterol Hepatol 2000; 12:727-31.
19. Agresti A. An Introduction to Categorical Data Analysis. New York: Wiley, 1996.
20. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
21. Fennerty MB, Lieberman DA, Vakil N, et al. Effectiveness of Helicobacter pylori therapies in a clinical practice setting. Arch Intern Med 1999;159:1562-6.
22. Fendrick AM, Chey WD, Margaret N, et al. Symptom status and the desire for Helicobacter pylori confirmatory testing after eradication therapy in patients with peptic ulcer disease. Am J Med 1999;107:133-6.
23. Chey WD, Fendrick AM. Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: A decision analysis to assess the effect of past infection on test choice. Arch Intern Med 2001;161:2129-32.
24. Asante MA, Mendall M, Patel P, et al. A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia. Eur J Gastroenterol Hepatol 1998;10:983-9.
25. Heaney A, Collins JS, Tham TC, et al. A prospective study of the management of the young Helicobacter pylori negative dyspeptic patient - Can gastroscopies be saved in clinical practice? Eur J Gastroenterol Hepatol 1998;10:953-6.
26. Heaney A, Collins JS, Watson RG, et al. A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999;45:186-90.
27. Duggan A, Elliot C, Tolley K, et al. Randomized controlled trial of four dyspepsia management strategies in primary care with 12 months follow-up. Gastroenterology 2000;118:A438 (abstract).
28. Ofman JJ, Rabeneck L. The effectiveness of endoscopy in the management of dyspepsia: A qualitative systematic review. Am J Med 1999;106:335-46.
29. Laheij RJ, Severens JL, Van de Lisdonk EH, et al. Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: A cost-effectiveness analysis. Aliment Pharmacol Ther 1998;12:1249-56.
30. Wiklund I, Glise H, Jerndal P, et al. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 1998;47:449-54.
31. Hirth RA, Bloom BS, Chernew ME, et al. Willingness to pay for diagnostic certainty: Comparing patients, physicians, and managed care executives. J Gen Intern Med 1999;14:193-5.
32. Hession PT, Malagelada J. The initial management of uninvestigated dyspepsia in younger patients-the value of symptom-guided strategies should be reconsidered. Aliment Pharmacol Ther 2000;14:379-88 (review article).
33. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994;120:977-81.
34. Hsu PI, Lai KH, Tseng HH, et al. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 2001;15:195-201.
35. Scheiman JM, Bandekar RR, Chernew ME, et al. Helicobacter pylori screening for individuals requiring chronic NSAID therapy: A decision analysis. Aliment Pharmacol Ther 2001; 15:63-71.
36. Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-73.
37. Parsonnet J, Harris RA, Hack HM, et al. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials. Lancet 1996;348: 150-4.
38. Fendrick AM, Chernew ME, Hirth RA, et al. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med 1999; 159:142-8.
39. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
40. Moayyedi P, Soo S, Deeks J, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. Br Med J 2000;321:659-64.